ZMAT3 and COVID-19: A previous GWAS study comparing symptomatic and asymptomatic patients of COVID-19 suggested a potential correlation between genetic variability in ZMAT3 and COVID-19 severity in the Chinese population [52], a finding that would endorse a possible role in relation to treatment response, although different risk polymorphisms were identified in both studies.